786 results

• Wegovy Vision Loss Risks 5 Times Higher Than Ozempic: Study

  March 13, 2026

  Irvin Jackson

  A new study links higher doses of semaglutide, the active ingredient in Ozempic and Wegovy, with increased vision loss risks, with Wegovy carrying five times the risk than Ozempic.

• GLP-1 Gout and Bone Fracture Risks Highlighted in New Studies

  March 10, 2026

  Irvin Jackson

  Two new studies warn that Ozempic, Mounjaro and similar drugs may be linked to increased risks of bone density loss, osteoporosis and gout, particularly in older patients.

• Ozempic NAION Side Effects Led to Blurred Vision, Lawsuit Alleges

  March 3, 2026

  Irvin Jackson

  A lawsuit over the side effects of Ozempic claims it led to a woman developing worsening blurred vision, even after she stopped taking the injections.

• Judge Appoints Attorneys to Leadership Positions in GLP-1 Vision Loss Lawsuits

  February 26, 2026

  Irvin Jackson

  A U.S. District Judge has appointed a group of 16 attorneys to work for the benefit of all plaintiffs with pending federal GLP-1 vision loss lawsuits.

• Study Finds No Link Between Side Effects of GLP-1s and Thyroid Cancer

  February 24, 2026

  Irvin Jackson

  A new report dismisses concerns linking drugs like Ozempic and Mounjaro to increased thyroid cancer risks, despite the drugs carrying a black box warning from the FDA.

• Ozempic, Wegovy NAION Risks Twofold Higher Compared to SGLT2i Drugs: Study

  February 19, 2026

  Irvin Jackson

  Researchers from Veterans' Affairs say that drugs like Ozempic and Wegovy carry double the risk of vision problems than other types of diabetes medications.

• Dexcom G6 Glucose Monitor Lawsuit Claims Manufacturer’s Device Modifications Resulted in Teen’s Death

  February 17, 2026

  Michael Adams

  A Colorado father alleges Dexcom’s unauthorized modifications to its G6 glucose monitor prevented critical alerts that led to his teenage son’s death, months before the company issued the first of several recalls over similar device issues.

• Lawsuit Claims NAION Vision Loss Caused by Ozempic Side Effects

  February 11, 2026

  Irvin Jackson

  An Ozempic NAION vision loss lawsuit claims Novo Nordisk knew, or should have known of the potential side effects for years.

• True Metrix Glucose Meter Warning Issued Over Error Code, Patient Death: FDA

  February 10, 2026

  Darian Hauf

  Following more than 100 reported injuries, federal regulators warn that some True Metrix blood glucose meters failed to prompt users to seek urgent medical care when error messages appeared alongside dangerously high blood sugar symptoms.

• FreeStyle Libre 3 Lawsuits Mount as FDA Issues Class I Glucose Monitor Recall

  February 5, 2026

  Michael Adams

  Federal health officials have issued a Class I recall of certain Abbott FreeStyle Libre 3 and Libre 3 Plus glucose monitor sensors after internal testing found the devices could display dangerously inaccurate low blood sugar readings for extended periods without alerting users.